Stay updated on Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page.

Latest updates to the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision (v3.4.2) was added to the study record history; the previous revision (v3.4.1) was removed along with its associated notice.SummaryDifference0.8%

- Check21 days agoChange DetectedA government funding status notice was added and the page revision label updated to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check28 days agoChange DetectedGlossary is now shown and the page uses green and red highlights to indicate additions and deletions, with the revision updated to v3.4.0 (No FEAR Act Data reflected in the UI). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check42 days agoChange DetectedRevision history shows an added Revision: v3.3.4 and removal of Revision: v3.3.3, reflecting an internal update to the site’s version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA new Revision: v3.3.3 entry appeared and the references to HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page footer. These are minor maintenance updates that do not affect study details or user-facing content, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check91 days agoChange DetectedThe history shows a new revision v3.3.2 and removal of v3.2.0, indicating administrative updates to the record rather than changes to trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page.